Estradiol 3-sulfate 17?-Glucuron

Confirm delete?

Estradiol 3-sulfate 17?-Glucuronide (potassium salt)

Zoom

Cat No: 18224

Biochemicals - Xenobiotic Metabolites

Estradiol 3-sulfate is a sulfated form of the steroid hormone 17β-estradiol (Item No. 10006315), and is common in fetal plasma and in the breast tissues of patients with mammary carcinoma.{29435,29434,20822} Sulfated estrogens, including estradiol 3-su...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

(17?)-3-(sulfooxy)estra-1,3,5(10)-trien-17-yl,?-D-glucopyranosiduronic acid, dipotassium salt

Correlated keywords:

906343-18-8 26923-03-5 biochemical metabolism steroid hormone endocrinology cancer metabolite dipotassium glucopyranosiduronic acid estrane

Product Overview:
Estradiol 3-sulfate is a sulfated form of the steroid hormone 17β-estradiol (Item No. 10006315), and is common in fetal plasma and in the breast tissues of patients with mammary carcinoma.{29435,29434,20822} Sulfated estrogens, including estradiol 3-sulfate, can be converted back to the parent compound by sulfatases.{20822,29433} Estradiol 3-sulfate 17β-glucuronide is a metabolite of estradiol 3-sulfate that has been modified by a UDP-glucuronosyltransferase. Glucuronidation of estrogens enhances their utilization by anion transporters, most commonly leading to excretion in urine and bile.{20822,26342}

Size	500 µg
Shipping	dry ice
CAS Number	10392-35-5
Molecular Formula	C₂₄H₃₀O₁₁S • 2K
SMILES	[H][C@]12[C@@]([C@@](CC[C@@H]3O[C@@]4([H])[C@H](O)[C@@H](O)[C@H](O)[C@@H](C([O-])=O)O4)([H])[C@]3(C)CC2)([H])CCC5=CC(OS([O-])(=O)=O)=CC=C51.[K+].[K+]
Molecular Weight	604,8
Formulation	A crystalline solid
Purity	≥95%
Custom Code	2937.23
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.